NYSE · PFE

Pfizer Inc.

$24.67 +$0.13 (+0.53%) 1D After hours
Session Pulse Overnight session chatter is louder than usual 1 mentions on Sat No new SEC filings since Mon close its sector ranked 5/11 this week Full pulse →
Charting by TradingView

Key Metrics

$139.86B
Market cap
18.67×
P/E · TTM
$63.32B
Revenue · TTM
$7.49B
Net income
EPS · TTM $1.31
Dividend yield —
Free cash flow $9.48B
Beta · 1Y 0.26
EBITDA · TTM $14.49B
Gross margin —

Snapshot

Market cap$139.86B
Enterprise value$194.40B
Shares outstanding5.7B
52-wk range$23.11 – $28.75
Avg volume · 20D36.2M
Net cash −$54.53B
Book value / share$15.78
IndustryPharmaceutical Preparations
ExchangeNYSE
About Pfizer Inc.
IPO dateJun 22, 1951
Employees75000

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E18.67
P/S2.21
P/FCF14.75
EV/EBITDA13.41
EV/Sales3.07
Graham №$21.58

Profitability

Gross —
Operating 12.5%
Net 11.8%
FCF 15.0%
ROE / ROIC 8.4% · 5.2%

Financial Health

Current ratio1.25
Quick ratio0.94
Debt / equity0.72
Debt / EBITDA 4.45
Net cash −$54.53B
Working capital$8.47B

Cash Flow · TTM

Operating CF $11.98B
Capex −$2.50B
Free cash flow $9.48B
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

2.0
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

$21.58 vs $24.67
Trades 1.1× above classic defensive value — priced for growth
Fundamentals through 2026-03-29 · computed by TickerWolf from SEC filings